The FDA has cleared a next-generation integrated continuous glucose monitor for people with diabetes aged 4 years and older, according to a press release from Abbott.
The FreeStyle Libre 3 is the CGM with the lowest overall mean absolute relative difference in glucose on the market, as well as the smallest and thinnest sensor developed to date, according to the release.
“The FreeStyle Libre 3 system is a direct result of listening to our customers — and giving them the innovation and sensing technology they’ve been looking for,» Jared Watkin, senior vice president of diabetes care